Novartis Pharma: The Business Unit Model Harvard Case Solution & Analysis

In June 2000, the reorganization of the Novartis pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The rest of the primary care products continues to be addressed in the framework of global functions (eg, R & D and marketing). The new organization created a matrix structure and new roles and responsibilities for the management of business functions, the leaders of a new business unit, and the country managers, working in more than 100 countries. "Hide
Srikant M. Datar by Karin-Isabel Knoop, Cate Reavis Source: Harvard Business School 21 pages. Publication Date: January 23, 2001. Prod. #: 101030-PDF-ENG

Related Case Solutions & Analyses:

Friendly Fenway Program: The Value of Experience Enhancement Erox Corp.: Leverage Marketing Population Services International: The Social Marketing Project in Bangladesh (Abridged) Stories That Deliver Business Insights Digital Marketing Strategy, Course Overview Note Verbeek Packaging Worldwide (C): The TotPet France Account ChemChina Fingerhut Pricing Strategy Hung Fook Tong: From Hong Kong to China Branding Citigroup’s Consumer Business